How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study

AIMS: Enrollment criteria vary substantially among cardiovascular outcome trials (CVOTs) of sodium‐glucose cotransporter‐2 inhibitors (SGLT‐2is), which impacts the relationship between a trial population and the general type 2 diabetes (T2D) population. The aim of this study was to evaluate the repr...

Descripción completa

Detalles Bibliográficos
Autores principales: Birkeland, Kåre I., Bodegard, Johan, Norhammar, Anna, Kuiper, Josephina G., Georgiado, Elena, Beekman‐Hendriks, Wendy L., Thuresson, Marcus, Pignot, Marc, Herings, Ron M. C., Kooy, Adriaan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590461/
https://www.ncbi.nlm.nih.gov/pubmed/30537226
http://dx.doi.org/10.1111/dom.13612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590461/
https://www.ncbi.nlm.nih.gov/pubmed/30537226
http://dx.doi.org/10.1111/dom.13612

Ejemplares similares